Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive Tract
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01116622 |
|
Recruitment Status :
Completed
First Posted : May 5, 2010
Last Update Posted : November 13, 2014
|
Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborators:
Genentech, Inc.
Ligand Pharmaceuticals
Information provided by (Responsible Party):
Dartmouth-Hitchcock Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 2014 |
| Actual Study Completion Date : | April 2014 |